IBDEI33I ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,51948,0)
 ;;=I69.820^^233^2548^4
 ;;^UTILITY(U,$J,358.3,51948,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51948,1,3,0)
 ;;=3^Aphasia following other cerebrovascular disease
 ;;^UTILITY(U,$J,358.3,51948,1,4,0)
 ;;=4^I69.820
 ;;^UTILITY(U,$J,358.3,51948,2)
 ;;=^5007522
 ;;^UTILITY(U,$J,358.3,51949,0)
 ;;=I69.220^^233^2548^5
 ;;^UTILITY(U,$J,358.3,51949,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51949,1,3,0)
 ;;=3^Aphasia following other nontraumatic intracranial hemorrhage
 ;;^UTILITY(U,$J,358.3,51949,1,4,0)
 ;;=4^I69.220
 ;;^UTILITY(U,$J,358.3,51949,2)
 ;;=^5007459
 ;;^UTILITY(U,$J,358.3,51950,0)
 ;;=I69.920^^233^2548^6
 ;;^UTILITY(U,$J,358.3,51950,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51950,1,3,0)
 ;;=3^Aphasia following unspecified cerebrovascular disease
 ;;^UTILITY(U,$J,358.3,51950,1,4,0)
 ;;=4^I69.920
 ;;^UTILITY(U,$J,358.3,51950,2)
 ;;=^5007553
 ;;^UTILITY(U,$J,358.3,51951,0)
 ;;=I69.390^^233^2548^7
 ;;^UTILITY(U,$J,358.3,51951,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51951,1,3,0)
 ;;=3^Apraxia following cerebral infarction
 ;;^UTILITY(U,$J,358.3,51951,1,4,0)
 ;;=4^I69.390
 ;;^UTILITY(U,$J,358.3,51951,2)
 ;;=^5007515
 ;;^UTILITY(U,$J,358.3,51952,0)
 ;;=I69.190^^233^2548^8
 ;;^UTILITY(U,$J,358.3,51952,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51952,1,3,0)
 ;;=3^Apraxia following nontraumatic intracerebral hemorrhage
 ;;^UTILITY(U,$J,358.3,51952,1,4,0)
 ;;=4^I69.190
 ;;^UTILITY(U,$J,358.3,51952,2)
 ;;=^5007452
 ;;^UTILITY(U,$J,358.3,51953,0)
 ;;=I69.090^^233^2548^9
 ;;^UTILITY(U,$J,358.3,51953,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51953,1,3,0)
 ;;=3^Apraxia following nontraumatic subarachnoid hemorrhage
 ;;^UTILITY(U,$J,358.3,51953,1,4,0)
 ;;=4^I69.090
 ;;^UTILITY(U,$J,358.3,51953,2)
 ;;=^5007420
 ;;^UTILITY(U,$J,358.3,51954,0)
 ;;=I69.890^^233^2548^10
 ;;^UTILITY(U,$J,358.3,51954,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51954,1,3,0)
 ;;=3^Apraxia following other cerebrovascular disease
 ;;^UTILITY(U,$J,358.3,51954,1,4,0)
 ;;=4^I69.890
 ;;^UTILITY(U,$J,358.3,51954,2)
 ;;=^5007546
 ;;^UTILITY(U,$J,358.3,51955,0)
 ;;=I69.290^^233^2548^11
 ;;^UTILITY(U,$J,358.3,51955,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51955,1,3,0)
 ;;=3^Apraxia following other nontraumatic intracranial hemorrhage
 ;;^UTILITY(U,$J,358.3,51955,1,4,0)
 ;;=4^I69.290
 ;;^UTILITY(U,$J,358.3,51955,2)
 ;;=^5007484
 ;;^UTILITY(U,$J,358.3,51956,0)
 ;;=I69.990^^233^2548^12
 ;;^UTILITY(U,$J,358.3,51956,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51956,1,3,0)
 ;;=3^Apraxia following unspecified cerebrovascular disease
 ;;^UTILITY(U,$J,358.3,51956,1,4,0)
 ;;=4^I69.990
 ;;^UTILITY(U,$J,358.3,51956,2)
 ;;=^5007568
 ;;^UTILITY(U,$J,358.3,51957,0)
 ;;=I69.91^^233^2548^13
 ;;^UTILITY(U,$J,358.3,51957,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51957,1,3,0)
 ;;=3^Cognitive deficits following unsp cerebrovascular disease
 ;;^UTILITY(U,$J,358.3,51957,1,4,0)
 ;;=4^I69.91
 ;;^UTILITY(U,$J,358.3,51957,2)
 ;;=^5007552
 ;;^UTILITY(U,$J,358.3,51958,0)
 ;;=I69.322^^233^2548^14
 ;;^UTILITY(U,$J,358.3,51958,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51958,1,3,0)
 ;;=3^Dysarthria following cerebral infarction
 ;;^UTILITY(U,$J,358.3,51958,1,4,0)
 ;;=4^I69.322
 ;;^UTILITY(U,$J,358.3,51958,2)
 ;;=^5007493
 ;;^UTILITY(U,$J,358.3,51959,0)
 ;;=I69.122^^233^2548^15
 ;;^UTILITY(U,$J,358.3,51959,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51959,1,3,0)
 ;;=3^Dysarthria following nontraumatic intracerebral hemorrhage
 ;;^UTILITY(U,$J,358.3,51959,1,4,0)
 ;;=4^I69.122
 ;;^UTILITY(U,$J,358.3,51959,2)
 ;;=^5007429
